<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03523910</url>
  </required_header>
  <id_info>
    <org_study_id>2015-1526</org_study_id>
    <secondary_id>1R01HL105598-01A1</secondary_id>
    <nct_id>NCT03523910</nct_id>
  </id_info>
  <brief_title>Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension</brief_title>
  <official_title>Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goals of this study were two-fold. First, the attempt to quantify the relationships
      between pulmonary arterial stiffness, right ventricular function and the efficiency of
      ventricular-vascular interactions in patients with pulmonary arterial hypertension (PAH).
      Second, the attempt to quantify the effects of exercise on pulmonary arterial stiffness,
      pulmonary vascular resistance, right ventricular function and the efficiency of
      ventricular-vascular interactions in patients with PAH.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goals of this study are to quantify right ventricular-pulmonary vascular interactions in
      different types of PAH, to determine the temporal changes in these interactions with PAH
      progression and to quantify the effects of exercise on right ventricular function. The
      inclusion of the subpopulation of PAH patients with systemic sclerosis (SSc) was a result of
      the anticipation that this group has worse arterial stiffening than other groups, and
      consequently more inefficient right ventricular-pulmonary vascular interactions, which
      account for their worse prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 25, 2012</start_date>
  <completion_date type="Actual">February 13, 2017</completion_date>
  <primary_completion_date type="Actual">February 13, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single center, open label, single-arm</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome is to comprehensively quantify right ventricular and pulmonary vascular function at rest and with exercise using magnetic resonance imaging.</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>The hypotheses will be tested by comprehensively quantifying ventricular and vascular function in subjects with idiopathic pulmonary arterial hypertension, systemic sclerosis pulmonary arterial hypertension, and chronic thromboembolic pulmonary hypertension, using investigational magnetic resonance angiography techniques.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Pulmonary Arterial Hypertension (PAH)</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A research MRI scan with exercise will be obtained in conjunction with standard of care cardiopulmonary testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI) with exercise</intervention_name>
    <description>MRI scan with a novel exercise device.</description>
    <arm_group_label>Patient</arm_group_label>
    <other_name>MRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of pulmonary arterial hypertension or a subtype

          2. Referred for right heart catheterization

          3. Age between 18 and 80 years

          4. New York Heart Association (NYHA) functional class I, II, or III

        Exclusion Criteria:

          1. Recent syncope (within 1 year)

          2. Severe skeletal or muscle abnormalities prohibiting exercise

          3. Mixed etiology pulmonary arterial hypertension

          4. Severe lung disease

               1. Test results indicating severe obstruction

               2. Total lung capacity &lt; 60%

          5. Pregnancy or breastfeeding

          6. NYHA class IV patient

          7. Contraindications to magnetic resonance imaging

          8. Kidney dysfunction as determined by an estimated glomerular filtration rate (eGFR) of
             &lt; 30 mL/min/1.73m2

          9. Contraindication to gadolinium
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Francois, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2018</study_first_submitted>
  <study_first_submitted_qc>May 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

